276 related articles for article (PubMed ID: 19563530)
1. Osteoblasts play key roles in the mechanisms of action of strontium ranelate.
Brennan TC; Rybchyn MS; Green W; Atwa S; Conigrave AD; Mason RS
Br J Pharmacol; 2009 Aug; 157(7):1291-300. PubMed ID: 19563530
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
3. Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate.
Fromigué O; Haÿ E; Barbara A; Petrel C; Traiffort E; Ruat M; Marie PJ
J Cell Mol Med; 2009 Aug; 13(8B):2189-99. PubMed ID: 20141614
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response.
Atkins GJ; Welldon KJ; Halbout P; Findlay DM
Osteoporos Int; 2009 Apr; 20(4):653-64. PubMed ID: 18763010
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
7. The Calcium-sensing Receptor (CaR) is involved in strontium ranelate-induced osteoblast differentiation and mineralization.
Takaoka S; Yamaguchi T; Yano S; Yamauchi M; Sugimoto T
Horm Metab Res; 2010 Aug; 42(9):627-31. PubMed ID: 20560105
[TBL] [Abstract][Full Text] [Related]
8. The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Mol Cell Biochem; 2012 Jan; 359(1-2):399-407. PubMed ID: 21874315
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro.
Bonnelye E; Chabadel A; Saltel F; Jurdic P
Bone; 2008 Jan; 42(1):129-38. PubMed ID: 17945546
[TBL] [Abstract][Full Text] [Related]
11. Activation of FGF receptors is a new mechanism by which strontium ranelate induces osteoblastic cell growth.
Caverzasio J; Thouverey C
Cell Physiol Biochem; 2011; 27(3-4):243-50. PubMed ID: 21471713
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate decreases receptor activator of nuclear factor-ΚB ligand-induced osteoclastic differentiation in vitro: involvement of the calcium-sensing receptor.
Caudrillier A; Hurtel-Lemaire AS; Wattel A; Cournarie F; Godin C; Petit L; Petit JP; Terwilliger E; Kamel S; Brown EM; Mentaverri R; Brazier M
Mol Pharmacol; 2010 Oct; 78(4):569-76. PubMed ID: 20584969
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins.
Choudhary S; Halbout P; Alander C; Raisz L; Pilbeam C
J Bone Miner Res; 2007 Jul; 22(7):1002-10. PubMed ID: 17371157
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms.
Caverzasio J
Bone; 2008 Jun; 42(6):1131-6. PubMed ID: 18378206
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
16. Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures.
Wornham DP; Hajjawi MO; Orriss IR; Arnett TR
Osteoporos Int; 2014 Oct; 25(10):2477-84. PubMed ID: 25048011
[TBL] [Abstract][Full Text] [Related]
17. The calcium-sensing receptor in bone metabolism: from bench to bedside and back.
Cianferotti L; Gomes AR; Fabbri S; Tanini A; Brandi ML
Osteoporos Int; 2015 Aug; 26(8):2055-71. PubMed ID: 26100412
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
Fernández JM; Molinuevo MS; Sedlinsky C; Schurman L; Cortizo AM; McCarthy AD
Eur J Pharmacol; 2013 Apr; 706(1-3):41-7. PubMed ID: 23499695
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of action of bisphosphonates and strontium ranelate].
Vengerovskiĭ AI; Khlusov IA; Nechaev KA
Eksp Klin Farmakol; 2014; 77(9):43-6. PubMed ID: 25365870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
